TRIM29 antibody (AA 309-588)
Quick Overview for TRIM29 antibody (AA 309-588) (ABIN6149518)
Target
See all TRIM29 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 309-588
-
Sequence
- ILEQNFRDLV RDLEKQKEEV RAALEQREQD AVDQVKVIMD ALDERAKVLH EDKQTREQLH SISDSVLFLQ EFGALMSNYS LPPPLPTYHV LLEGEGLGQS LGNFKDDLLN VCMRHVEKMC KADLSRNFIE RNHMENGGDH RYVNNYTNSF GGEWSAPDTM KRYSMYLTPK GGVRTSYQPS SPGRFTKETT QKNFNNLYGT KGNYTSRVWE YSSSIQNSDN DLPVVQGSSS FSLKGYPSLM RSQSPKAQPQ TWKSGKQTML SHYRPFYVNK GNGIGSNEAP
-
Cross-Reactivity
- Human, Mouse, Rat
-
Characteristics
- Polyclonal Antibodies
-
Immunogen
- Recombinant fusion protein containing a sequence corresponding to amino acids 309-588 of human TRIM29 (NP_036233.2).
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB,1:500 - 1:2000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- TRIM29 (Tripartite Motif Containing 29 (TRIM29))
-
Alternative Name
- TRIM29
-
Background
- The protein encoded by this gene belongs to the TRIM protein family. It has multiple zinc finger motifs and a leucine zipper motif. It has been proposed to form homo- or heterodimers which are involved in nucleic acid binding. Thus, it may act as a transcriptional regulatory factor involved in carcinogenesis and/or differentiation. It may also function in the suppression of radiosensitivity since it is associated with ataxia telangiectasia phenotype.,TRIM29,ATDC,Epigenetics & Nuclear Signaling,Transcription Factors,Cell Biology & Developmental Biology,Cell Cycle,Cell differentiation,TRIM29
-
Molecular Weight
- 63 kDa/65 kDa
-
Gene ID
- 23650
-
UniProt
- Q14134
-
Pathways
- p53 Signaling, Apoptosis, DNA Damage Repair, Inositol Metabolic Process, Positive Regulation of Response to DNA Damage Stimulus
Target
-